Natriumchlorid Grifols (Sodium Chloride)

Sodium chloride, the active ingredient in Natriumchlorid Grifols, is a saline presented as an injection solution for intravenous use. It belongs to the fluid and electrolyte replenishment therapeutic class and is employed to restore extracellular fluid volume and electrolyte balance in patients who require fluid replacement, such as those experiencing hypovolemia, dehydration, or postoperative losses.

GNH USA supplies Natriumchlorid Grifols as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, ensuring consistent quality and regulatory conformity across global markets.

Natriumchlorid Grifols is a saline solution used in the management of fluid and electrolyte disorders.

- Fluid replacement: Restores intravascular volume in patients with acute blood loss or dehydration. - Electrolyte balance: Provides sodium and chloride to correct electrolyte disturbances during surgery or critical illness. - Hypovolemia: Replenishes circulating volume in conditions such as shock or severe fluid depletion.

Intravenous administration of Natriumchlorid Grifols may be associated with adverse reactions.

Common Side Effects: - Injection site pain: Mild discomfort or burning sensation at the infusion site. - Hypernatremia: Elevated serum sodium levels, especially with large volumes. - Fluid overload: Signs of excess volume such as peripheral edema. - Fever: Transient rise in body temperature during infusion.

Serious or Rare Side Effects: - Anaphylactic reaction: Severe hypersensitivity requiring immediate medical intervention. - Pulmonary edema: Accumulation of fluid in the lungs leading to respiratory distress. - Cardiac arrhythmia: Abnormal heart rhythm due to electrolyte disturbances. - Severe hyperchloremia: Marked increase in chloride levels causing metabolic acidosis.

When using Natriumchlorid Grifols, several precautions should be observed to ensure patient safety.

- Assess volume status: Evaluate patient’s fluid balance before initiating therapy. - Monitor electrolytes: Check serum sodium and chloride levels regularly during infusion. - Adjust infusion rate: Tailor administration speed to avoid rapid shifts in plasma osmolarity. - Use compatible solutions: Ensure compatibility with other IV fluids to prevent precipitation. - Contraindications: Avoid use in patients with severe hypernatremia or uncontrolled heart failure. - Store at ambient temperature: Keep in original container, protect from moisture and direct sunlight.

Natriumchlorid Grifols can interact with certain medications, affecting fluid and electrolyte balance.

Major Interactions (Avoid): - Loop diuretics: May cause excessive sodium loss and worsen hypovolemia. - ACE inhibitors/ARBs: Can potentiate hyperkalemia when combined with large-volume saline. - Hypertonic glucose solutions: Co‑administration may lead to rapid shifts in osmolarity.

Moderate Interactions (Monitor Closely): - Corticosteroids: May increase sodium retention, requiring electrolyte monitoring. - Anticoagulants: Large-volume infusions can dilute plasma proteins, affecting coagulation. - Vasopressors: Adjust dosing as volume status changes with saline administration.